The role of atherosclerosis in osteoarthritis

被引:22
作者
Bierma-Zeinstra, S. M. A. [1 ,2 ]
Waarsing, J. H. [2 ]
机构
[1] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gen Practice, POB 2040, NL-3000 CA Rotterdam, Netherlands
[2] Univ Med Ctr Rotterdam, Erasmus MC, Dept Orthoped, POB 2040, Rotterdam, Netherlands
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2017年 / 31卷 / 05期
关键词
Osteoarthritis; Atherosclerosis; ARTERY WALL THICKNESS; KNEE OSTEOARTHRITIS; STATIN USE; CARDIOVASCULAR-DISEASE; HAND OSTEOARTHRITIS; WEIGHT-LOSS; HIP OSTEOARTHRITIS; SYMPTOMATIC HAND; LOWER PREVALENCE; RISK-FACTORS;
D O I
10.1016/j.berh.2018.08.006
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
In recent years, several papers that report an association between atherosclerosis (AS) and osteoarthritis (OA) have been published. Studying this relation is, however, not a sinecure owing to the multifactorial nature of these diseases and their long lead-in times. In this review, we discuss the evidence that is currently available for the association between OA and both subclinical AS and AS-related cardiovascular disease (CVD) events. We found that evidence from most studies points toward an association between AS and OA in the hands or knee of particularly postmenopausal women. Further, we investigate the possibilities and evidence for an explanation of this association. There is some evidence that AS might influence the progression of OA. Thus far, no studies have investigated possible common pathways that lead to the co-development of both diseases. However, ample literature that suggests possibilities for these pathways is available, and many of these pathways are linked to the innate immune system. Understanding the exact nature of how AS and OA are linked together might lead to new biomarkers and common treatments for these diseases in subgroups of patients. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:613 / 633
页数:21
相关论文
共 102 条
[1]
The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease [J].
Ascher, Stefanie ;
Reinhardt, Christoph .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 (04) :564-575
[2]
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[3]
Hip Osteoarthritis and the Risk of All-Cause and Disease-Specific Mortality in Older Women: A Population-Based Cohort Study [J].
Barbour, Kamil E. ;
Lui, Li-Yung ;
Nevitt, Michael C. ;
Murphy, Louise B. ;
Helmick, Charles G. ;
Theis, Kristina A. ;
Hochberg, Marc C. ;
Lane, Nancy E. ;
Hootman, Jennifer M. ;
Cauley, Jane A. .
ARTHRITIS & RHEUMATOLOGY, 2015, 67 (07) :1798-1805
[4]
Menopause, atherosclerosis, and coronary artery disease [J].
Barrett-Connor, Elizabeth .
CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (02) :186-191
[5]
Baudart P, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2017-000442
[6]
Role of hormones in cartilage and joint metabolism: understanding an unhealthy metabolic phenotype in osteoarthritis [J].
Bay-Jensen, Anne C. ;
Slagboom, Eline ;
Chen-An, Pingping ;
Alexandersen, Peter ;
Qvist, Per ;
Christiansen, Claus ;
Meulenbelt, Ingrid ;
Karsdal, Morten A. .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (05) :578-586
[7]
The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover [J].
Bay-Jensen, Anne-Christine ;
Tabassi, Nadine C. B. ;
Sondergaard, Lene V. ;
Andersen, Thomas L. ;
Dagnaes-Hansen, Frederik ;
Garnero, Patrick ;
Kassem, Moustapha ;
Delaisse, Jean-Marie .
ARTHRITIS RESEARCH & THERAPY, 2009, 11 (01) :R9
[8]
Beattie MS, 2005, J RHEUMATOL, V32, P106
[9]
Impaired aortic elastic properties in primary osteoarthritis [J].
Belen, Erdal ;
Karaman, Ozgur ;
Caliskan, Gurkan ;
Atamaner, Oya ;
Aslan, Omer .
VASCULAR, 2016, 24 (01) :70-77
[10]
Belen E, 2015, INT J CLIN EXP MED, V8, P9491